Healthy Skepticism Library item: 9542

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

McLaughlin SS.
Novel promotional activities, direct-to-consumer advertising subjects of FDA scrutiny
American Journal of Hospital Pharmacy 1989 May; 46:870, 875

Abstract:

The Food and Drug Administration’s stance on regulating new promotional activities of direct-to-consumer advertising of prescription drugs is discussed. FDA cannot regulate where an advertisement is placed or what form it takes, but it can ensure that these new advertising modes comply with regulations imposed on more conventional forms of advertising, such as advertisements in professional journals.